Myriad Genetics Inc (MYGN)

Operating profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Operating income (ttm)	US$ in thousands	-101,700	-115,800	-155,900	-233,100	-257,400	-272,000	-256,900	-161,000	-123,700	-120,800	-155,700	-158,700	-190,500	-195,600	-155,300	-202,800	-289,800	-250,400	-231,700	-169,000
Revenue (ttm)	US$ in thousands	837,600	823,600	802,200	774,200	753,200	734,400	698,900	694,700	678,400	661,400	672,300	682,400	690,600	684,400	662,300	566,100	557,000	597,500	638,600	760,800
Operating profit margin		-12.14%	-14.06%	-19.43%	-30.11%	-34.17%	-37.04%	-36.76%	-23.18%	-18.23%	-18.26%	-23.16%	-23.26%	-27.58%	-28.58%	-23.45%	-35.82%	-52.03%	-41.91%	-36.28%	-22.21%

December 31, 2024 calculation

Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $-101,700K ÷ $837,600K
= -12.14%

The operating profit margin of Myriad Genetics Inc has shown a decreasing trend over the past few years. From the negative value of -22.21% as of March 31, 2020, the margin deteriorated further to -36.28% by June 30, 2020, and continued declining to reach its lowest point of -52.03% by December 31, 2020.

Despite some fluctuations, the operating profit margin has generally remained negative through March 31, 2024. Over the last few quarters, the margin has gradually improved, showing a marked decrease in negative values. By December 31, 2024, the operating profit margin had significantly improved to -12.14%.

The company's management may need to focus on strategies to increase revenues and/or reduce operating expenses to continue this positive trend and eventually achieve a positive operating profit margin.